|
|
|
Company Name
|
Hyperion Therapeutics, Inc.
|
|
Drug Name
|
Ravicti (NDA)
|
|
Event Name
|
FDA decision on Ravicti for treatment of urea cycle disorder
|
|
Event Date
|
10/23/2012
|
|
Outcome
|
FDA decision postponed to January 23, 2013
|
|
Drug Status
|
|
|
Rival Drugs
|
|
|
Market Potential
|
|
|
Other Approvals
|
|
|
News |
|
|
|
Return to FDA Calendar
|